Surgery May Improve Survival in Older Patients With Invasive Breast Cancer
Surgery was an independent predictor of overall survival.
Breast Cancer
Keytruda Combo Approved for High-Risk Early-Stage Triple-Negative Breast Cancer
The approval was based on data from the phase 3 KEYNOTE-522 trial, which included 1174 patients with newly diagnosed previously untreated high-risk early-stage TNBC.
Overcoming Obstacles to Health Equity in Breast Cancer Prevention and Control
The current scientific evidence may not be generalizable to underrepresented groups.
Racial Disparities in Survival Among Triple-Negative Breast Cancer Patients Partially Explained by Treatment Differences
The study showed differences in receipt of chemotherapy and surgery but not radiotherapy.
On-Treatment Ki-67: A Promising Prognostic Marker for Early Breast Cancer Management
Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Age and Stage at Breast Cancer Diagnosis Don’t Account for Racial Disparities in Distant Metastases
Black patients were more likely than White patients to have distant metastases.
Long-Term Follow-Up Confirms Utility of MammaPrint to Guide Treatment of Breast Cancer
Older breast cancer patients with high clinical risk but low genomic risk have “excellent” 8-year distant metastasis-free survival when treated with endocrine therapy alone.
- Loading...
Loading...
Next post in News
Loading... 
Loading...